DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the DR. LAL PATH LABS LTD. (LALPATHLAB) share price today?

DR. LAL PATH LABS LTD. (LALPATHLAB) is trading at ₹1,687.4 on the NSE, down 2.61% on the day. Source: DocStoX.

What is the PE ratio of DR. LAL PATH LABS LTD.?

DR. LAL PATH LABS LTD. has a price-to-earnings (PE) ratio of 56.0 in the Healthcare sector.

What is the market capitalisation of DR. LAL PATH LABS LTD.?

DR. LAL PATH LABS LTD. has a market capitalisation of approximately ₹28,262 crore.

DR. LAL PATH LABS LTD.

LALPATHLAB·NSE·Healthcare

₹1,687.40▼ -45.30 (-2.61%)

Healthcare · Healthcare Service Provider

Debt-free and consistently profitable

NIFTY 500NIFTY SMALLCAP 250

Day₹1666.20

₹1733.00

52W₹1273

₹354018%

Open

₹1732.70

High

₹1733.00

Low

₹1666.20

Prev Close

₹1732.70

Volume

2.13L

VWAP

₹1691.44

Snapshot

Key fundamentals

Market Cap

₹28,262 Cr

P/E Ratio

56.00Expensive

P/B Ratio

11.26

EPS

₹30.13

Book Value

₹150.00

ROE

22.50%Strong

ROCE

28.00%Efficient

Dividend Yield

1.22%

Debt / Equity

0.08Low

Face Value

₹10.00

52W High

₹3540.00

52W Low

₹1272.60

Sector

Healthcare

Industry

Healthcare Service Provider

Avoid

Narrow moatHigh uncertainty

Fair value estimate

₹239

▼ 85.8%downside

Trading at ₹1,687 — 86% above our estimate

BearFair valueBull

₹203₹239₹319

/100

Business quality — Solid

Growth 72Profitability 89Efficiency 50Valuation 48

Plain English

Our view

Debt-free and consistently profitable
Virtually debt-free balance sheet
Fundamental red flags (Piotroski 1/9)

Strengths

Virtually debt-free balance sheet
Strong returns on equity (23%)
Capital is working hard (ROCE 28%)
Profit growing 28% a year

Risks

Fundamental red flags (Piotroski 1/9)

How we got there

Fair value methods

Residual income

23% ROE fading to 12% over ~10 yrs, on ₹150 book

₹217

Relative P/E

Needs ≥3 peers with P/E

—

Graham floor

Conservative floor: √(22.5 × EPS × book value/share)

₹319

Analyst target

No analyst coverage

—

Blended fair value₹239

What the numbers say

Investment thesis

Bull case

Virtually debt-free balance sheet
Strong returns on equity (23%)
Capital is working hard (ROCE 28%)
Profit growing 28% a year
Promoters hold a controlling stake

Bear case

Fundamental red flags (Piotroski 1/9)

Free — see our deterministic Fair Value range, business quality score, and the full bull/bear case for this stock.

Snapshot

Key statistics

P/E

56.0Expensive

Below 15× is value territory; above 35× prices in strong growth

ROE

22.5%Strong

Above 15% is considered healthy for Indian equities

ROCE

28.0%Efficient

Above 18% means capital is working hard

Debt/Eq

0.08Low

Below 0.5 is comfortable; above 1.5 strains the balance sheet

Mkt Cap

₹28,262 Cr

P/B

11.26

EPS

₹30.13

Div Yield

1.22%

What changed

Recent changes

Foreign investors-3.1% stake last quarter
Domestic institutions+2.2% stake last quarter

What matters

News impact

Overview

Valuation

Expensive

P/E 56.0×

Growth

Steady

+11% rev CAGR

Profitability

Excellent

22.5% ROE

Financial health

Rock solid

D/E 0.08

Momentum

N/A

No technicals

Today

Trading activity

Delivery %45.9%

Turnover₹3594.89L Cr

Trades30,551

VWAP₹1691.44

Face value₹10.00

Market depth

Market depth available during market hours

Snapshot

Technical signals

Compounded annual growth

Growth (CAGR)

Revenue

+11.1%

+11.8%

10Y

+13.3%

Profit

+28.4%

+11.5%

10Y

+14.4%

EPS

+28.1%

+11.5%

10Y

+14.2%

Profile

Pros

Company is almost debt free.
Company has been maintaining a healthy dividend payout of 36.4%

Watch-outs

Cons

Stock is trading at 11.3 times its book value
The company has delivered a poor sales growth of 11.8% over past five years.

Forecast

News

Peers

Financials

Growth

Shareholding

Ownership

Ownership breakdown

Quarter ending 31 Mar 2026

Foreign investors sold 3.11 pts; domestic institutions added 2.17 pts last quarter. The QoQ column shows each group's change versus the prior quarter.

53%

Promoter

Promoters

53.2%0.00

Public

7.9%+0.94

FII / FPI

17.2%-3.11

DII

21.4%+2.17

Total shareholders

1,14,527+142 QoQ

Quarterly trend

Ownership over time

Q4 FY26

Promoter53.21%

FII17.18%

DII21.37%

Government0.01%

Public7.88%

Others0.35%

Corporate Actions

Bulk & Block Deals

Filings

MF Holdings

Technicals

FAQs

Quick reference

Frequently asked questions